Nymox Pharmaceutical Corp SMA 50
Quel est le SMA 50 de Nymox Pharmaceutical Corp?
Le SMA 50 de Nymox Pharmaceutical Corp est $0 -12.25%
Quelle est la définition de SMA 50?
SMA 50 est un cours moyen des 50 derniers jours calculé comme une moyenne non pondérée des 50 derniers cours de clôture.
Simple moving average of 50 days for a stock is an unweighted moving average over the past 50 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.
Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.
SMA 50 des entreprises dans Health Care secteur sur NASDAQ par rapport à Nymox Pharmaceutical Corp
Que fait Nymox Pharmaceutical Corp?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Entreprises avec sma 50 similaire à Nymox Pharmaceutical Corp
- Thermal International a SMA 50 de CAD$0 +5.15%
- Gome Finance Technology Co a SMA 50 de HKD$0 +38.84%
- Impac Mortgage a SMA 50 de $0 +0.70%
- European Metals a SMA 50 de AUD$0 -31.43%
- China Kangda Food a SMA 50 de HKD$0 -11.73%
- Yorkton Ventures a SMA 50 de CAD$0 +13.85%
- Nymox Pharmaceutical Corp a SMA 50 de $0 -12.25%
- Cosmos Machinery Enterprises a SMA 50 de HKD$0 -3.69%
- Komet Resources a SMA 50 de CAD$0 +94.96%
- Sierra Metals Inc a SMA 50 de $0 -9.92%
- Outcrop Gold a SMA 50 de CAD$0 -2.48%
- Defiance Silver a SMA 50 de CAD$0 +13.28%
- Modern Media a SMA 50 de HKD$0 -15.11%